Way to spin it negative in the your topic. They don't have to submit the IDA in the EU because they are approved for predialysis in the EU. As opposed to the US where the roadblock called the FDA only approved them for dialysis patients, and warned that if they used Auryxia they might have to decrease or stop IV iron, like that would be a bad thing.
dip at the open then a recovery during the day. In a trading range and today did nothing to change that.
Or somebody is closing a covered call position in case the price jumps in the next 2 weeks. Only tomorrow will tell when we can see if the OI goes up or down from 2025
any day RI66 will show back up again and tell us how he knew it was going up all the time. And to fill us in on his SEC investigation on naked shorting
Why would the company put out a press release if they have no new information to share. It isn't the job of the company to rehash old news so that message board posters will be satisfied.
Next press release will be one of 4 things, in order of likely to happen (IMO):
1. Filed for expanded label with the FDA
2. Q2 earnings report
4. EU partner
I see one glaring error, they don't have $125 mil, it's the stock that they have to issue to Baupost so they actually have $170 mil and are debt free.
He hasn't bought a share on the open market in close to 1 year, what makes you think he would start now? The only logically reason to buy more would be if he was going to take the company private and I doubt that is in his game plan.